from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3881c/espB

LFCtreatmentdescriptionclass of inhibitor

0.041

Amikacinug/mL Amikacintranslation

0.372

Cap5-10ug/mL Capreomycintranslation

1.304

Rox10-50 ug/mL Roxithromycintranslation

0.249

SM2-5 ug/mL Streptomycintranslation

-0.001

Tet5-10 ug/mL Tetracyclinetranslation

-0.934

Rif0.2-5ug/mL Rifampicintranscription

-0.286

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.668

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.555

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.261

CPZ10-50 ug/mL Chlorpromazinerespiration

1.145

Clofazimine10-13 ug/mL Clofaziminerespiration

0.493

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.754

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.333

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.192

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.700

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.017

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.347

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.578

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.916

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.602

KCN5-20 ug/mL Potassium cyaniderespiration

-0.270

NaN30.2-2 mM Sodium aziderespiration

0.362

Nigericin50 uM Nigericinrespiration

0.385

TRC10-150 ug/mL Triclosanrespiration

2.589

TRZ10-25 ug/mL Thioridazinerespiration

1.177

Valinomycin0.5-10 uM Valinomycinrespiration

-0.659

ZnSO42 mM ZnSO4respiration

0.339

menadione6-10 ug/mL Menadionerespiration

0.393

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.459

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.042

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.395

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.983

NRP_1Non-replicating persistence stage 1dosRassociated

-0.003

Amp0.2mg/mL AmpicillincellWall

0.313

Cephalexin20-100 ug/mL CephalexincellWall

0.289

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.869

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.583

EMB10-20 ug/mL EthambutolcellWall

0.286

Eta12-40 ug/mL EthionamidecellWall

0.191

INH0.2-0.4 ug/mL IsoniazidcellWall

0.271

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.146

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.029

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.669

BZA0.12 mg/mL BenzamidearomaticAmides

-0.390

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.563

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.004

H2O24 mM hydrogen peroxideDNAdamaging

-0.264

Levo10 ug/mL LevofloxacinDNAdamaging

-1.044

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.895

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.554

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.400

UVUV-irradiationDNAdamaging

0.294

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.381

Antimycin12.5-50 ug/mL Antimycin A?

0.013

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.126

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.158

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.391

PA8240.2-2 ug/mL PA-824?

0.069

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.200

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.493

Verapamil50 uM Verapamil?

-0.150

mercaptoethanol2 mM 2-Mercaptoethanol?

0.291

methoxatin10-20 ug/mL Methoxatin?